Jianjun Wu

Jianjun Wu


Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 February 2023 in npj Parkinson's Disease
Verified
Journal Article
Open access
PDF file
YTYilin Tang
Yilin Tang
LHLinlin Han
Linlin Han
SLShiyu Li
Shiyu Li
THTianyu Hu
Tianyu Hu
ZXZhiheng Xu
Zhiheng Xu
Jian WangJian Wang
Jian Wang
Glial fibrillary acidic protein (GFAP) has been suggested as a biomarker for reactive astrogliosis. We measured the levels of plasma GFAP by Simoa in 60 patients with PD with normal cognition, 63 with mild cognitive impairment (PD-MCI), 24 with dementia (PDD) and 15 healthy controls. A subgroup of patients with PD-MCI (n = 31) was followed up for 4.1 ± 2.3 years. Compared with healthy controls, plasma GFAP levels were elevated in patients with PDD (adjusted P < 0.001) and PD-MCI (adjusted P = 0.013) and were negatively correlated with the Mini Mental State Examination (MMSE) score in PD participants. Plasma GFAP predicted MCI-to-dementia conversion with an AUC of 0.90, higher than NfL, Tau and pTau181. Our results support that plasma GFAP has potential value for distinguishing patients with PDD, and predicting MCI-to-dementia conversion in PD.

1 April 2021 in Neurotherapeutics
Verified
Journal Article
Closed access
PDF file
LBLu-Lu Bu
Lu-Lu Bu
YLYi-Qi Liu
Yi-Qi Liu
YSYan Shen
Yan Shen
YFYun Fan
Yun Fan
WYWen-Bo Yu
Wen-Bo Yu
Jian WangJian Wang
Jian Wang

24 August 2017 in Health and Quality of Life Outcomes
Verified
Journal Article
Open access
PDF file
KCKui Chen
Kui Chen
YYYu-Jie Yang
Yu-Jie Yang
FLFeng-Tao Liu
Feng-Tao Liu
DLDa-Ke Li
Da-Ke Li
LBLu-Lu Bu
Lu-Lu Bu
JWJianjun Wu
Jianjun Wu
Parkinson’s disease is characterized by motor and non-motor symptoms with wide ranging impacts on the health-related quality of life. The 39-item Parkinson’s disease Questionnaire (PDQ-39) is the most widely used PD-specific health-related quality-of-life questionnaire. The short-form 8-item Parkinson’s disease Questionnaire (PDQ-8) was found to produce results similar to that of the PDQ-39 cross-culturally. However, there is no evaluation of the PDQ-8 in the mainland of China. In this longitudinal study, 283 patients with Parkinson’s disease were recruited. The PDQ-39, the PDQ-8 and other scales were administered. Patients attended the clinic once annually for three years to complete the scales. The PDQ-8 was found to have good validity and reliability. There was a strong correlation between the summary indices of the PDQ-8 and the PDQ-39 (r=0.93, P<0.001). Results suggested that the PDQ-8 was also associated with other clinical scales of mobility, depression and cognition. The convergent validity and discriminant validity of the PDQ-8 were demonstrated by item-to-dimension correlations. There was acceptable internal consistency of the PDQ-8 (Cronbach’s α: 0.80; Item-scale correlation efficient: 0.56–0.72). The PDQ-8 replicated the results of the PDQ-39 well at all follow-up time points (intraclass correlation coefficient: 0.96–0.98). In addition, there was good test-retest reliability of the PDQ-8. The PDQ-8 is a valid and reliable instrument assessing health-related quality of life for PD patients in the mainland of China.

27 October 2020 in Movement Disorders
Verified
Journal Article
Closed access
PDF file
YSYi-Min Sun
Yi-Min Sun
HYHui‐Ling Yu
Hui‐Ling Yu
XZXin‐Yue Zhou
Xin‐Yue Zhou
WXWeixi Xiong
Weixi Xiong
SLSu‐Shan Luo
Su‐Shan Luo
Jian WangJian Wang
Jian Wang

8 July 2016 in Journal of Neurology
Verified
Journal Article
Closed access
PDF file
WXWeixi Xiong
Weixi Xiong
YSYi-Min Sun
Yi-Min Sun
RGRong-Yuan Guan
Rong-Yuan Guan
SLSu-Shan Luo
Su-Shan Luo
CCChen Chen
Chen Chen
JWJianjun Wu
Jianjun Wu

17 May 2023 in npj Parkinson's Disease
Verified
Journal Article
Open access
PDF file
YSYi-Min Sun
Yi-Min Sun
XZXin-Yue Zhou
Xin-Yue Zhou
XLXiao-Niu Liang
Xiao-Niu Liang
JLJin-Ran Lin
Jin-Ran Lin
YXYi-Dan Xu
Yi-Dan Xu
Jian WangJian Wang
Jian Wang
So far, over 20 causative genes of monogenic Parkinson’s disease (PD) have been identified. Some causative genes of non-parkinsonian entities may also manifest with parkinsonism mimicking PD. This study aimed to investigate the genetic characteristics of clinically diagnosed PD with early onset age or family history. A total of 832 patients initially diagnosed with PD were enrolled, of which, 636 were classified into the early-onset group and 196 were classified into the familial late-onset group. The genetic testing included the multiplex ligation-dependent probe amplification and next generation sequencing (target sequencing or whole-exome sequencing). The dynamic variants of spinocerebellar ataxia were tested in probands with family history. In the early-onset group, 30.03% of patients (191/636) harbored pathogenic/likely pathogenic (P/LP) variants in known PD-related genes (CHCHD2, DJ-1, GBA (heterozygous), LRRK2, PINK1, PRKN, PLA2G6, SNCA and VPS35). Variants in PRKN were the most prevalent, accounting for 15.72% of the early-onset patients, followed by GBA (10.22%), and PLA2G6 (1.89%). And 2.52% (16/636) had P/LP variants in causative genes of other diseases (ATXN3, ATXN2, GCH1, TH, MAPT, GBA (homozygous)). In the familial late-onset group, 8.67% of patients (17/196) carried P/LP variants in known PD-related genes (GBA (heterozygous), HTRA2, SNCA) and 2.04% (4/196) had P/LP variants in other genes (ATXN2, PSEN1, DCTN1). Heterozygous GBA variants (7.14%) were the most common genetic cause found in familial late-onset patients. Genetic testing is of vital importance in differential diagnosis especially in early-onset and familial PD. Our findings may also provide some clues to the nomenclature of genetic movement disorders.